Jose V. Garcia-Hervas
Sant Joan Despi, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biological and clinical stability after switching from intravenous to subcutaneous natalizumab in RRMS under standard and extended dosing.
Journal: Frontiers in immunology
Published: May 12, 2026
Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
Journal: Neurologia
Published: August 10, 2021
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.
Journal: Mediators of inflammation
Published: October 31, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial.
Journal: European journal of neurology
Published: July 08, 2018
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.
Journal: CNS neuroscience & therapeutics
Published: November 01, 2017
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Journal: Cytometry. Part B, Clinical cytometry
Published: December 13, 2016
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
Journal: Neurologia (Barcelona, Spain)
Published: June 29, 2015
Myelitis: Differences between multiple sclerosis and other aetiologies.
Journal: Neurologia (Barcelona, Spain)
Published: March 30, 2015
Multiple Intracranial Arteriovenous Fistulas in Cowden Syndrome.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: February 19, 2015
Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms
Journal: Revista de neurologia
Published: December 18, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026